Form EFFECT Esperion Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 15, 2026 |
| Accession Number: | 0001104659-26-083013 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IQST - IQSTEL Reaches $450 Million Annualized Revenue Run Rate Based on $37.5 Million in July Net Revenue
- Findem Launches Studio: People Intelligence, Built for AI, That Returns Finished Work Teams Can Trust
- Accenture Edge Collaborates with AWS to Help Mid-Market Organizations Harness AI and Accelerate Business Impact
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
